Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Pre-participation screening of young competitive athletes for prevention of sudden cardiac death 3. The Job Market for 2008-2009: Compensation 4. Renal Artery Stenosis 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesPercutaneous transvenous mitral annuloplasty: Initial human experience with a novel coronary sinus implant device
Circulation: Cardiovascular Interventions, 06/25/09
Sack S et al. – Percutaneous implantation of a novel coronary sinus mitral repair device (PTMA) is feasible and safe. Acute results show a possibly meaningful reduction of mitral regurgitation (MR) in responding pts. Sustained favorable geometric modification of the mitral annulus is reported, despite limited reduction of MR.
Methods- Study of the safety and feasibility of permanent implantation of PTMA device
- Subjects: symptomatic (NYHA class 2 or 3) pts with primarily functional MR
- Diagnostic PTMA procedure in coronary sinus venous continuity
- Assessment of MR, then PTMA device adjustment to optimize efficacy
- PTMA implant placement attempted if MR reduction (≤1 grade)
- Echocardiographic, quality of life, and exercise capacity metrics evaluation of implanted pts
- Diagnostic PTMA study for 19 pts
- Diagnostic PTMA effective in 13 pts: MR grade 3.2±0.6 reduced to 2.0±1.0
- PTMA implants placed in 9 pts
- Uneventful removal of 4 devices (7, 84, 197, 216 days), 3 for annuloplasty surgery due to observed PTMA device migration and/or diminished efficacy
- No procedure or device-related major adverse events with permanent sequela in any diagnostic or implant pts
- Sustained reductions of mitral annulus septal-lateral dimension from 3D echo reconstruction dimensions (4.0±1.2 mm at 3 mo)
Today in Interventional...keeping you current
Receive free subspecialty "5-minute updates" via email
Effectiveness of Two-Year Clopidogrel + Aspirin in Abolishing the Risk of Very Late Thrombosis After Drug-Eluting Stent Implantation (from the TYCOON [Two-Year ClOpidOgrel Need] Study)
The American Journal of Cardiology, 11/05/09
Carotid artery stenting vs. endarterectomy
European Heart Journal, 10/30/09
Dofetilide is safe and effective in preventing atrial fibrillation recurrences in patients accepted for catheter ablation
Europace, 10/15/09
Today in Valvular Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Use of Low Molecular Weight Heparin in Pregnant Women With Mechanical Heart Valves
The American Journal of Cardiology, 10/22/09
Effect of Mitral Regurgitation on Cerebrovascular Accidents in Patients with Atrial Fibrillation and Left Atrial Thrombus
Clinical Cardiology, 10/13/09
Aortic Valve Stenosis
Anesthesiology Clinics, 10/16/09
Sponsor
Article Search
Sponsor
Sponsor